Cargando…
Chemical Biology Screening Identifies a Vulnerability to Checkpoint Kinase Inhibitors in TSC2-Deficient Renal Angiomyolipomas
The tuberous sclerosis complex (TSC) is a rare genetic syndrome and multisystem disease resulting in tumor formation in major organs. A molecular hallmark of TSC is a dysregulation of the mammalian target of rapamycin (mTOR) through loss-of-function mutations in either tumor suppressor TSC1 or TSC2....
Autores principales: | Vaughan, Robert M., Kordich, Jennifer J., Chan, Chun-Yuan, Sasi, Nanda K., Celano, Stephanie L., Sisson, Kellie A., Van Baren, Megan, Kortus, Matthew G., Aguiar, Dean J., Martin, Katie R., MacKeigan, Jeffrey P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8960247/ https://www.ncbi.nlm.nih.gov/pubmed/35359406 http://dx.doi.org/10.3389/fonc.2022.852859 |
Ejemplares similares
-
DDK Has a Primary Role in Processing Stalled Replication Forks to Initiate Downstream Checkpoint Signaling
por: Sasi, Nanda Kumar, et al.
Publicado: (2018) -
DDK Promotes Tumor Chemoresistance and Survival via Multiple Pathways
por: Sasi, Nanda Kumar, et al.
Publicado: (2017) -
Response to everolimus is seen in TSC-associated SEGAs and angiomyolipomas independent of mutation type and site in TSC1 and TSC2
por: Kwiatkowski, David J, et al.
Publicado: (2015) -
Angiomyolipoma Have Common Mutations in TSC2 but No Other Common Genetic Events
por: Qin, Wei, et al.
Publicado: (2011) -
Germline mutation of TSC1 or TSC2 gene in Chinese patients with bilateral renal angiomyolipomas and mutation spectrum of Chinese TSC patients
por: Jiangyi, Wang, et al.
Publicado: (2020)